Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cox

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.
Cancer Research|December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug developmentDong Lin, Alexander W Wyatt, Hui Xue, et al.
Oncotarget|February 2, 2017
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistanceMannan Nouri, Josselin Caradec, Amy Anne Lubik, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.
Cancer Research|December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug developmentDong Lin, Alexander W Wyatt, Hui Xue, et al.
Oncotarget|February 2, 2017
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistanceMannan Nouri, Josselin Caradec, Amy Anne Lubik, et al.
Pageof 7